A Prospective Open-Label Trial of Buspirone for the Treatment of Anxiety in Williams Syndrome
{{output}}
Study Design: Prospective open-label trial. Objectives: The objective of this study was to determine whether buspirone showed preliminary evidence of effectiveness, safety, and tolerability in individuals with Williams syndrome (WS). Methods: This is a 16-week... ...
